Phcog.Net logo

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Article

    Inhibitory Effects of Dioscoreae Rhizoma and Polygalae Radix Mixture Combined with Sorafenib in Hepatoma Xenografts Model

    Mi-Rae Shin1, Jeong Won Choi2, Seong-Soo Roh1 Corresponding author

    1. 1Department of Herbology, College of Korean Medicine, Daegu Haany University, Daegu, REPUBLIC OF KOREA.
    2. 2Department of Forest Science, Andong National University, Andong, Republic of Korea Corresponding author: Seong-Soo Roh, College of Korean Medicine, Daegu Haany University, 136, Sincheondong-ro, Suseong-gu, Daegu, 42158, Republic of Korea. E-mail: ddede@dhu.ac.kr.

    CORRESPONDENCE

    Seong-Soo Roh

    Department of Herbology, College of Korean Medicine, Daegu Haany University, Daegu, REPUBLIC OF KOREA.

    ddede@dhu.ac.kr

    Received: 08-01-2024; Accepted: 31-05-2024.

    Volume 21, Issue 1 · pp. 89–98 · PUBLISHED 2025 · DOI: 10.1177/09731296241262566

    View on Pharmacogn. Mag. original site ↗

    ABSTRACT

    Background: Hepatocellular carcinoma (HCC) is one of the most common malignancies and a leading cause of cancerrelated mortality and morbidity worldwide. Objectives: This study evaluated the enhanced efficacy of a combination of herbal medicine with sorafenib (MIX) in a transplantation tumor model induced by HepG2 cells in HCC. Materials and Methods: The HepG2 cell transplantation tumor model was established by injecting HepG2 cells subcutaneously into BALB/c nude mice. The impact of MIX on tumor growth was observed. Granzyme B was used to measure natural killer (NK) cell activity. Prognostic markers of HCC, telomerase reverse transcriptase (TERT), and alphafetoprotein (AFP) were analyzed via real-time polymerase chain reaction. Additionally, inflammation and apoptosis-related markers were assessed through serum analysis and Western blotting. Results: Among the MIX groups, MIX25 (sorafenib 10 mg/kg + Dioscoreae rhizoma and Polygalae radix mixture 25 mg/kg) demonstrated the most significant effect. MIX25 effectively suppressed tumor volume and weight, enhanced apoptosispromoting proteins (Bax, Cytochrome c, and Caspase-3), and reduced apoptosis-inhibiting proteins like survivin. Furthermore, MIX25 inhibited the mitogen-activated protein kinase inflammatory response and inflammatory markers, including tumor necrosis factor-alpha and cyclooxygenase-2. The MIX25 group exhibited superior effects on NK cell activity and cancer marker genes (AFP and TERT) compared to other drug-treated groups. Conclusion: MIX25 effectively suppressed the proliferation of HepG2 cell transplantation tumors in BALB/c nude mice. It not only inhibited inflammatory markers but also enhanced cell apoptosis. Additionally, MIX25 significantly increased NK cell activity and reduced mRNA expressions of AFP and TERT. Overall, the combination of MIX25 with sorafenib shows promise as a potential treatment for patients with HCC.

    KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Shin, M., Choi, J. W., & Roh, S. (2025). Inhibitory Effects of Dioscoreae Rhizoma and Polygalae Radix Mixture Combined with Sorafenib in Hepatoma Xenografts Model. Pharmacognosy Magazine, 21(1), 89–98. https://doi.org/10.1177/09731296241262566